Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19

Laser treatment of Neuropathic Pain after COVID-19

Autores

  • Fernanda Cruz Gomes São Leopoldo Mandic, Departamento de Odontopediatria, Campinas, SP, Brazil
  • Christian Naurath Instituto Nacional do Câncer, Rio de Janeiro, RJ, Brazil
  • Luciane Azevedo USP
  • Denise Maria Zezell Instituto de Pesquisas Energéticas e Nucleares, Centro de Lasers e Aplicações, São Paulo, SP, Brazil.

DOI:

https://doi.org/10.4322/bds.2021.e2962

Resumo

Objective: The purpose of this short communication is to show that although photobiomodulation in the
treatment of neurophathic oral pain after COVID-19 contagion could be an option, photobiomodulation is not
a new technique. PBMT was used with different protocols and pain was assessed using VAS (visual analogue
scale - 0 until 10) before and after the consultation. Results: Evolution of VAS during the sessions showed a
decrease in painful symptomatology as treatment was performed. Conclusion: Based on the results obtained in
the present case report, we concluded that PBMT with the parameters used in this clinical case was an effective,
noninvasive and a new option of treatment for neuralgia resulting from COVID-19.
KEYWORDS
Laser; Photobiomodulation therapy; COVID-19; Oral neuralgia.

Downloads

Não há dados estatísticos.

Downloads

Publicado

2021-12-17

Como Citar

1.
Gomes FC, Naurath C, Azevedo L, Zezell DM. Photobiomodulation therapy to treat neuropathic oral pain after contagion by COVID-19: Laser treatment of Neuropathic Pain after COVID-19. BDS [Internet]. 17º de dezembro de 2021 [citado 13º de setembro de 2025];24(4 Suppl). Disponível em: https://bds.ict.unesp.br/index.php/cob/article/view/2962

Edição

Seção

Artigo de Caso Clínico / Descrição de Técnica

Artigos mais lidos pelo mesmo(s) autor(es)